The Neuroregenerative Effects of IncobotulinumtoxinA (Inco/A) in a Nerve Lesion Model of the Rat
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157482 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Oscar Sánchez-Carranza und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nonclinical Sciences & Operations, Merz Therapeutics GmbH, Eckenheimer Landstraße 100, D-60318 Frankfurt, Germany. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Nerve Regeneration, Sciatic Nerve, Peripheral Nerve Injuries. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merz Therapeutics GmbH.
Abstract (Originalsprache)
The use of Botulinum Neurotoxin A (BoNT/A) to treat peripheral neuropathic pain from nerve injury has garnered interest for its long-lasting effects and safety. This study examined the effects of IncobotulinumtoxinA (Inco/A), a BoNT/A variant without accessory proteins, on nerve regeneration in rats using the chronic constriction injury (CCI) model. Inco/A was administered perineurally at two time points: on days 0 and 21 post CCI. Functional and histological assessments were conducted to evaluate the effect of Inco/A on nerve regeneration. Sciatic Functional Index (SFI) measurements and Compound Muscle Action Potential (CMAP) recordings were conducted at different time points following CCI. Inco/A-treated animals exhibited a 65% improved SFI and 22% reduction in CMAP onset latencies compared to the vehicle-treated group, suggesting accelerated functional nerve recovery. Tissue analysis revealed enhanced remyelination in Inco/A-treated animals and 60% reduction in CGRP and double S100β signal expression compared to controls. Strikingly, 30% reduced immune cell influx into the injury site was observed following Inco/A treatment, suggesting that its anti-inflammatory effect contributes to nerve regeneration. These findings show that two injections of Inco/A promote functional recovery by enhancing neuroregeneration and modulating inflammatory processes, supporting the hypothesis that Inco/A has a neuroprotective and restorative role in nerve injury conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nonclinical Sciences & Operations, Merz Therapeutics GmbH, Eckenheimer Landstraße 100, D-60318 Frankfurt, Germany.
- Neurotoxin Biotechnology Development, Merz Therapeutics GmbH, Eckenheimer Landstraße 100, D-60318 Frankfurt, Germany.
ORCID-Profile: Oscar Sánchez-Carranza, Jens Nagel
Förderung
- Merz Therapeutics GmbH
Zitieren
APA
Sánchez-Carranza, O., Danysz, W., Fink, K., Ruitenberg, M., Gravius, A., & Nagel, J. (2025). The Neuroregenerative Effects of IncobotulinumtoxinA (Inco/A) in a Nerve Lesion Model of the Rat. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157482
Vancouver
Sánchez-Carranza O, Danysz W, Fink K, Ruitenberg M, Gravius A, Nagel J. The Neuroregenerative Effects of IncobotulinumtoxinA (Inco/A) in a Nerve Lesion Model of the Rat. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157482
BibTeX
@article{SnchezCarranza2025,
author = {Sánchez-Carranza, Oscar and Danysz, Wojciech and Fink, Klaus and Ruitenberg, Maarten and Gravius, Andreas and Nagel, Jens},
title = {The Neuroregenerative Effects of IncobotulinumtoxinA (Inco/A) in a Nerve Lesion Model of the Rat},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157482}
}
EUVIMED